[Modulation of sympathetic activity by ghrelin in the central nervous system].
Matsumura
Kiyoshi
K
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D017704:Baroreflex / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology; D015195:Drug Design; D054439:Ghrelin; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D036361:Peptide Hormones / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D043562:Receptors, G-Protein-Coupled / Q000502:physiology; D054440:Receptors, Ghrelin; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects
D054439:Ghrelin; D036361:Peptide Hormones; D043562:Receptors, G-Protein-Coupled; D054440:Receptors, Ghrelin